Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors

1 year ago

SEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo and off-the-shelf therapies…

Acies Bio and Protein Evolution Announce Strategic Partnership to Advance Biological Recycling Technology

1 year ago

LJUBLJANA, Slovenia, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Protein Evolution, a pioneer in enzyme-driven plastics recycling, has announced a collaboration…

Redhook Brewery and Montlake Futures Team Up to Launch Montlake Gameday Gold Lager, a New Craft Beer in Support of University of Washington Athletes

1 year ago

SEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Redhook Ale Brewery (“Redhook”), Seattle’s pioneering craft brewery and a subsidiary of Tilray…

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

1 year ago

Article Focuses on how Leading Physicians are Incorporating Nociscan Into Their Clinical Practices for Chronic Low Back Pain Patients MAGNETOM…

SPR® Therapeutics Debuts New SPRINT® PNS Data for Low Back, Shoulder, Knee, and Headache at the 23rd Annual ASRA Pain Medicine Meeting

1 year ago

Presentations include first reporting of data for the RESET™ Clinical Trial evaluating SPRINT PNS versus Standard Interventional Management for low…

Biolojic Design Appoints Neal Curran as Chief Business Officer

1 year ago

REHOVOT, Israel and WASHINGTON, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Biolojic Design, a biotechnology company that uses computational biology and…

Humacyte Clinical Results Highlighting Benefit of the ATEV™ in the Repair of Civilian and Military Arterial Injuries Published in JAMA Surgery

1 year ago

– In two studies the acellular tissue engineered vessel (ATEV) provided benefits in terms of patency, limb salvage, and infection…

Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split

1 year ago

The Company's class A ordinary shares will begin trading on a split-adjusted basis on November 25, 2024FOSTER CITY, Calif., Nov.…

Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial

1 year ago

MORRISVILLE, N.C., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, was…

Nanox Announces Third Quarter of 2024 Financial Results and Provides Business Update

1 year ago

Made progress deploying all components of the Nanox solution including Nanox.ARC and Nanox.AI Expanded US sales and support staff a…